Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Acarbose for prevention of diabetes mellitus. STOP-NIDDM]].

× No keyword cloud information.

16 in total

1. Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM.

Authors: M Hanefeld; S Fischer; H Schmechel; G Rothe; J Schulze; H Dude; U Schwanebeck; U Julius
Journal: Diabetes Care Date: 1991-04 Impact factor: 19.112

2. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112

3. Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis.

Authors: O Vaccaro; G Ruffa; G Imperatore; V Iovino; A A Rivellese; G Riccardi
Journal: Diabetes Care Date: 1999-09 Impact factor: 19.112

4. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors: J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal: N Engl J Med Date: 2001-05-03 Impact factor: 91.245

5. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.

Authors: H E Resnick; M I Harris; D B Brock; T B Harris
Journal: Diabetes Care Date: 2000-02 Impact factor: 19.112

6. The effect of acarbose on insulin sensitivity and proinsulin in overweight subjects with impaired glucose tolerance.

Authors: H Laube; T Linn; P Heyen
Journal: Exp Clin Endocrinol Diabetes Date: 1998 Impact factor: 2.949

Review 7. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

Authors: N Unwin; J Shaw; P Zimmet; K G M M Alberti
Journal: Diabet Med Date: 2002-09 Impact factor: 4.359

8. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus.

Authors: J L Chiasson; R Gomis; M Hanefeld; R G Josse; A Karasik; M Laakso
Journal: Diabetes Care Date: 1998-10 Impact factor: 19.112

9. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors: Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal: Lancet Date: 2002-06-15 Impact factor: 79.321

10. The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study.

Authors: F de Vegt; J M Dekker; C D Stehouwer; G Nijpels; L M Bouter; R J Heine
Journal: Diabetes Care Date: 1998-10 Impact factor: 19.112

1 in total

1. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Authors: Suzanne Vl Moelands; Peter Lbj Lucassen; Reinier P Akkermans; Wim Jc De Grauw; Floris A Van de Laar
Journal: Cochrane Database Syst Rev Date: 2018-12-28

1 in total